Cross-disorder genetic analyses implicate dopaminergic signaling as a biological link between Attention-Deficit/Hyperactivity Disorder and obesity measures
Nina Roth MotaiD, Geert PoelmansiD, Marieke KleiniD, Bàrbara Torrico, Noèlia Fernàndez-castillo AiD, Bru CormandiD, Andreas ReifiD, Barbara FrankeiD, Alejandro Arias VásqueziD
Abstract
Attention-Deficit/Hyperactivity Disorder (ADHD) and obesity are frequently comorbid, genetically correlated, and share brain substrates. The biological mechanisms driving this association are unclear, but candidate systems, like dopaminergic neurotransmission and circadian rhythm, have been suggested. Our aim was to identify the biological mechanisms underpinning the genetic link between ADHD and obesity measures and investigate associations of overlapping genes with brain volumes. We tested the association of dopaminergic and circadian rhythm gene sets with ADHD, body mass index (BMI), and obesity (using GWAS data of N=53,293, N=681,275, and N=98,697, respectively). We then conducted genome-wide ADHD-BMI and ADHD-obesity gene-based meta-analyses, followed by pathway enrichment analyses. Finally, we tested the association of ADHD-BMI overlapping genes with brain volumes (primary GWAS data N=10,720-10,928; replication data N=9,428). The dopaminergic gene set was associated with both ADHD (P=5.81x10-3) and BMI (P=1.63x10-5), the circadian rhythm was associated with BMI (P=1.28x10-3). The genome-wide approach also implicated the dopaminergic system, as the Dopamine-DARPP32 Feedback in cAMP Signaling pathway was enriched in both ADHD-BMI and ADHD-obesity results. The ADHD-BMI overlapping genes were associated with putamen volume (P=7.7x10-3; replication data P=3.9x10-2) - a brain region with volumetric reductions in ADHD and BMI and linked to inhibitory control. Our findings suggest that dopaminergic neurotransmission, partially through DARPP-32-dependent signaling and involving the putamen, is a key player underlying the genetic overlap between ADHD and obesity measures. Uncovering shared etiological factors underlying the frequently observed ADHD-obesity comorbidity may have important implications in terms of prevention and/or efficient treatment of these conditions.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 39
- FWCI
- 4.19
- Field percentile
- top 5%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Comprehensive exploration of the genetic contribution of the dopaminergic and serotonergic pathways to psychiatric disorders
Judit Cabana‐Domínguez, Bàrbara Torrico, … Bru Cormand·Translational PsychiatryPeer-reviewed·Jan 10, 2022
- DRD2/ANKK1 Taq1A but not COMT single nucleotide polymorphisms contribute to the link between temporal impulsivity and obesity in men
Filip Morys, Jakob Simmank, Annette Horstmann·bioRxiv·Jun 2, 2020
- Unravelling the joint genetic architecture between psychiatric and insulin-related traits in the general population
Barbara Sakic, Izel Erdogan, … Janita Bralten·medRxiv·Oct 4, 2024
- The pleiotropic contribution of genes in dopaminergic and serotonergic pathways to addiction, aggression, and related behavioural traits
Ester Antón-Galindo, Judit Cabana‐Domínguez, … Noèlia Fernàndez-castillo A·medRxiv·May 3, 2023
- Working Memory Gating in Obesity is Moderated by Striatal Dopaminergic Gene Variants
Nadine Herzog, Hendrik Hartmann, … Annette Horstmann·eLifePeer-reviewed·Oct 21, 2024
- Investigating regions of shared genetic variation in attention deficit/hyperactivity disorder and major depressive disorder: A GWAS meta-analysis
Victoria E. Powell, Joanna Martin, … Richard Anney·Scientific ReportsPeer-reviewed·Apr 1, 2021